Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam with sufentanil for painless fiberoptic bronchoscopy
ChiCTR2500113068Phase 4Recruiting
- Sponsor
- Ankang Traditional Chinese Medicine Hospital
- Start
- Nov 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam, midazolam and sufentanil in anxiety disorder (2 arms), sponsored by Ankang Traditional Chinese Medicine Hospital. Primary endpoint: Richmond Agitation-Sedation Scale (RASS) score. Started Nov 2025; status: recruiting.
02
Drugs
remimazolammidazolamsufentanil
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2500113068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113068.